Is intraperitoneal onlay mesh plus (IPOM‑PLUS) technique superior to standard intraperitoneal onlay mesh (IPOM) repair for ventral hernia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

IPOM-PLUS is Superior to Standard IPOM for Ventral Hernia Repair

IPOM-PLUS (with fascial defect closure) should be the preferred technique over standard IPOM for laparoscopic ventral hernia repair, as it significantly reduces hernia recurrence and mesh bulging without substantially increasing complications.

Key Evidence Supporting IPOM-PLUS

The most recent and highest quality randomized controlled trial 1 directly comparing IPOM, IPOM-PLUS, and IPOM with peritoneal bridging (IPOM-Pb) in 120 patients with moderate midline ventral hernias (3-6 cm defects) demonstrated that IPOM-PLUS provides the most balanced outcomes. While this 2026 study showed similar early seroma rates and pain scores across all three techniques, it identified only one recurrence at 6 months—which occurred in the standard IPOM group, not the IPOM-PLUS group.

Recurrence Rates: The Critical Difference

A 2022 retrospective cohort study 2 of 130 patients provides the most compelling evidence for IPOM-PLUS superiority regarding recurrence. Six-month recurrence was 15.1% after standard IPOM versus only 3.5% after IPOM-PLUS (p=0.029). The adjusted odds ratio revealed that IPOM repair had 14.86 times higher risk of recurrence compared to IPOM-PLUS (95% CI: 2.51-87.85, p=0.003).

For large incisional hernias (≥10 cm), a 2018 study 3 showed that 50% of standard IPOM cases developed mesh bulging versus 0% in IPOM-PLUS (p=0.0082), which is a precursor to recurrence and represents functional failure even without frank herniation.

Trade-offs to Consider

Operative time: IPOM-PLUS consistently requires longer operative time—approximately 30 minutes more 1, 2. The mean operative time is 111 minutes for IPOM-PLUS versus 80 minutes for standard IPOM 2.

Infection risk: One 2026 retrospective analysis 4 found higher paraprosthetic infection rates with IPOM-PLUS (6.9% vs 2.26%, p<0.05), though this finding conflicts with other studies showing comparable complication rates 1, 5.

Pain outcomes: Multiple studies demonstrate no significant difference in postoperative pain between IPOM and IPOM-PLUS at any time point 1, 5. A 2026 meta-analysis 5 of 5 RCTs (n=549) confirmed no difference in pain scores (SMD: 0.26,95% CI [-0.17,0.69], p=0.23).

Seroma formation: Results are mixed. The 2026 RCT 1 showed similar seroma rates between IPOM and IPOM-PLUS, while the meta-analysis 5 found no significant difference (RR: 0.78,95% CI: [0.32,1.88], p=0.58).

Clinical Algorithm for Technique Selection

Choose IPOM-PLUS when:

  • Defect size is 2-10 cm (most evidence supports this range)
  • Patient can tolerate 30 additional minutes of operative time
  • Primary goal is minimizing recurrence risk
  • Patient has acceptable surgical risk profile

Consider standard IPOM only when:

  • Operative time must be minimized (hemodynamically unstable patient, severe comorbidities)
  • Defect is very small (<2 cm) where recurrence risk may be acceptably low
  • Technical factors prevent safe fascial closure

Avoid IPOM with peritoneal bridging (IPOM-Pb): This technique showed higher seroma rates and longer operative times without demonstrable benefits 1.

Important Caveats

The available guidelines [6-6] address emergency hernia repair with contaminated fields but do not specifically compare IPOM versus IPOM-PLUS techniques. These guidelines focus on mesh selection based on CDC wound classification rather than laparoscopic technique variations.

The evidence base has limitations: Most studies have relatively short follow-up (6 months to 2 years), and the dramatic recurrence difference seen in the retrospective study 2 was not fully replicated in the RCT 1, though the single recurrence in that trial occurred in the IPOM group. Longer-term data consistently favor fascial closure techniques across hernia surgery literature.

For emergency/contaminated cases: Follow the WSES guidelines 6 which recommend synthetic mesh for CDC class I-II wounds and biological mesh for class III-IV, but these don't address the IPOM versus IPOM-PLUS question specifically.

The preponderance of evidence, particularly the 14-fold reduction in recurrence risk 2, supports IPOM-PLUS as the superior technique when technically feasible, accepting the trade-off of modestly longer operative time for substantially better durability.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.